The global vulvovaginal candidiasis treatment market is currently valued at USD 1035 million in 2023 and is anticipated to expand at a CAGR of 4.5%. Owing to the technological advances in healthcare ...

Mundipharma has announced that rezafungin is now available in the Republic of Ireland for adult patients with invasive ...

The following is a summary of “Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients ...

Thrush and bacterial vaginosis (BV) are common vaginal infections that can cause symptoms including abnormal discharge. They are also both easily treatable, but Deborah Bateson says because there is ...

New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) </ ...

Celltrion, Inc. today announced that six abstracts will be presented at the 2025 Digestive Disease Week® (DDW) Annual Meeting, taking place May 3-6 in San Diego, California. The oral and poster ...

The newly secured $3 million in funding will help to accelerate the company’s development and bring its flagship product, ...

Treatment for this condition often involves a course of antibiotics. An infection in the vagina caused by yeast can lead to a burning sensation. The medical term for this is candidiasis.

[1] It is imperative that health care providers diagnose mammary candida early to prevent complications of mild nipple candidiasis. Adequate treatment and support can prevent breastfeeding ...

Other names for a penile yeast infection include candida balanitis, candidiasis ... foreskin, or both. Treatment for balanitis depends on the underlying cause. A doctor will treat a penile ...